J.B. Chemicals & Pharma (Large Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
J. B. Chemicals & Pharmaceuticals Limited |
|||
|
Price: ₹1,792.75 (-0.54%) | ||
| 52 Week Low: ₹1,480.00 52 Week High: ₹2,030.00 |
|||
| Market Capital: 26,451.56 Crore (Largecap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: J.B. Chemicals & Pharma Share Price Target For 2025
- 1.1.1: J.B. Chemicals & Pharma Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: J.B. Chemicals & Pharma Share Price Target For 2026
- 1.2.1: J.B. Chemicals & Pharma Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: J.B. Chemicals & Pharma Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: J.B. Chemicals & Pharma Brief Company Overview
- 4: J.B. Chemicals & Pharma Financial Performance
- 4.0.1: Is J.B. Chemicals & Pharma A Good Buy For Long Term?
J.B. Chemicals & Pharma, a Large Cap company in the Drug Manufacturers—Specialty & Generic Industry has delivered 671.1% returns in 5-year showing 13.5% quarterly revenue growth with 16.5% profit margin, making it a potential Multibagger.
To predict the J.B. Chemicals & Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
J.B. Chemicals & Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of J.B. Chemicals & Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for J.B. Chemicals & Pharma shares in 2025, see the table below.
J.B. Chemicals & Pharma Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1910.0 (+6.54%) | Price Action: 10 Sep 2024 Low |
| 2025 Target 2 | 1891.05 (+5.48%) | Price Action: 16 Sep 2024 Low |
| 2025 Target 1 | 1871.8 (+4.4%) | Price Action: 02 Jan 2025 High |
| Current Price | 1792.75 | J.B. Chemicals & Pharma's share price as of 21 Jan 2025 |
| Stop Loss 1 | 1755.9 (-2.06%) | Price Action: 11 Nov 2024 Low |
| Stop Loss 2 | 1737.95 (-3.06%) | Price Action: 03 Jun 2024 Low |
| Stop Loss 3 | 1720.01 (-4.05%) | Price Action: 05 Apr 2024 High |
Short-Term Technical Outlook
Current Technical Position: J.B. Chemicals & Pharma is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹1800.24 serves as the nearest technical reference point.
Historical Returns: 3-month: -8.58% | 6-month: -6.53% | 1-year: +7.19%
J.B. Chemicals & Pharma Share Price Target For 2026
The line chart displays the monthly closing prices of J.B. Chemicals & Pharma with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for J.B. Chemicals & Pharma shares in 2026, see the table below.
J.B. Chemicals & Pharma Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 2664.66 (+48.63%) | Price Action: Chart |
| 2026 Target 2 | 2614.98 (+45.86%) | Fibonacci Extension Level 150.00% |
| 2026 Target 1 | 2552.06 (+42.35%) | Fibonacci Extension Level 64.90% |
| Current Price | 1792.75 | J.B. Chemicals & Pharma's share price as of 21 Jan 2025 |
| Stop Loss 1 | 1617.15 (-9.8%) | Price Action: 22 Jan 2024 High |
| Stop Loss 2 | 1593.4 (-11.12%) | Price Action: 07 Mar 2024 High |
| Stop Loss 3 | 1574.52 (-12.18%) | Price Action: 05 Mar 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: J.B. Chemicals & Pharma is currently trading at 56.9% of its 52-week range (₹1480 - ₹2030).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +7.19% | 3-year: +112.52% | 5-year: +671.08%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
J.B. Chemicals & Pharma Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,792.75 | ||
| 2025 | ₹2,718.48 | +51.63% | ₹2,759.26 |
| 2026 | ₹4,063.52 | +49.47% | ₹4,124.47 |
| 2027 | ₹5,483.89 | +34.95% | ₹5,566.15 |
| 2028 | ₹7,441.56 | +35.69% | ₹7,553.18 |
| 2029 | ₹10,459.57 | +40.55% | ₹10,616.46 |
| 2030 | ₹12,208.76 | +16.72% | ₹12,391.89 |
| 2031 | ₹14,942.67 | +22.39% | ₹15,166.81 |
| 2032 | ₹20,074.62 | +34.34% | ₹20,375.74 |
| 2033 | ₹25,866.27 | +28.85% | ₹26,254.26 |
| 2034 | ₹33,717.26 | +30.35% | ₹34,223.02 |
| 2035 | ₹39,956.40 | +18.5% | ₹40,555.75 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
J.B. Chemicals & Pharma Brief Company Overview
J. B. Chemicals & Pharmaceuticals: A Pharmaceutical Powerhouse Established in 1976, J. B. Chemicals & Pharmaceuticals Limited is a leading pharmaceutical enterprise with a global footprint. Headquartered in Mumbai, India, the company boasts a diverse product portfolio,...
catering to a wide range of therapeutic areas. Key Products: Pharmaceutical formulations Herbal remedies Active pharmaceutical ingredients (APIs) Contrast media products Services: Contract manufacturing Custom formulations Market Presence: With operations in India and international markets, J. B. Chemicals is a renowned name in the pharmaceutical industry. Commitment: The company is driven by its commitment to innovation, quality, and patient care, ensuring the delivery of effective and affordable healthcare solutions.J.B. Chemicals & Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 26,451.56 Crore | Market valuation of J.B. Chemicals & Pharma's shares. |
| Revenue (TTM) | 3,711.26 Crore | Total revenue generated by J.B. Chemicals & Pharma over the past twelve months. |
| Net Income (TTM) | +611.12 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +22.85% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +16.46% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+13.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+15.9% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
3.12 | Company's total debt divided by total shareholder equity. |
| Total Debt | 100.2 Crore | Sum of J.B. Chemicals & Pharma's current & long-term financial obligations. |
| Total Cash | 416.86 Crore | Total amount of liquid funds available to J.B. Chemicals & Pharma. |
| Beta | -0.02 | Beta is less than 1 indicating that the J.B. Chemicals & Pharma's price is less volatile than the market. |
Is J.B. Chemicals & Pharma A Good Buy For Long Term?
J.B. Chemicals & Pharma, a large-cap stock with a market capitalization of ₹26,451.56 crore, shows mixed signals. While its 5-year return of 469.27% is impressive, recent performance is weaker (-9.42% past 3 months). A healthy profit margin of 16.46% and positive cash balance (₹416.86 crore) are encouraging. However, the relatively small debt (₹100.2 crore) isn't a major concern. Considering the volatile recent performance, it's an average buy for the long term, requiring further analysis before a strong recommendation.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
